BAYESIAN-ESTIMATION AND PREDICTION OF CLEARANCE IN HIGH-DOSE METHOTREXATE INFUSIONS

被引：50

作者：

ILIADIS, A ^{[1
]}

BACHIRRAHO, M ^{[1
]}

BRUNO, R ^{[1
]}

FAVRE, R ^{[1
]}

机构：

[1] INST PAOLI I CALMETTES,MARSEILLE 9,FRANCE

来源：

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1985年 / 13卷 / 01期

关键词：

D O I：

10.1007/BF01073659

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：101 / 115

页数：15

共 32 条

[1]

Anderson TW., 1958, INTRO MULTIVARIATE S

[2]

BLEYER WA, 1978, CANCER-AM CANCER SOC, V41, P36, DOI 10.1002/1097-0142(197801)41:1<36::AID-CNCR2820410108>3.0.CO

[3]

2-I

[4] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].

BOXENBAU.HG ;

RIEGELMA.S ;

ELASHOFF, RM .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148

[5]

CHABNER BA, 1975, CANCER CHEMOTH REP 3, V6, P1

[6]

EVANS WE, 1980, APPLIED PHARMACOKINE

[7]

Eykhoff P., 1974, SYSTEM IDENTIFICATIO, V1st ed.

[8] HIGH-DOSE METHOTREXATE - A CLINICAL AND PHARMACOKINETIC EVALUATION - TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK USING A PROSPECTIVE MATHEMATICAL-MODEL AND PHARMACOKINETIC SURVEILLANCE [J].

FAVRE, R ;

MONJANEL, S ;

ALFONSI, M ;

PRADOURA, JP ;

BAGARRYLIEGEY, D ;

CLEMENT, S ;

IMBERT, AM ;

LENA, N ;

DISTRIA, JC ;

CANO, JP ;

CARCASSONNE, Y .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) :156-160

[9]

Fletcher R., 1980, PRACTICAL METHODS OP, V1

[10] PRIORI LITHIUM DOSAGE REGIMEN USING POPULATION CHARACTERISTICS OF PHARMACOKINETIC PARAMETERS [J].

GAILLOT, J ;

STEIMER, JLJ ;

MALLET, AJ ;

THEBAULT, JJ ;

BIEDER, A .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (06) :579-628

← 1 2 3 4 →